Saturday, July 11, 2026

Drug profile · INN

chiauranib

chiauranib is a serine/threonine-protein kinase aurora-b inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — chiauranib
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

chiauranib is a serine/threonine-protein kinase aurora-b inhibitor.

Key facts

INN chiauranib
Mechanism Serine/threonine-protein kinase Aurora-B inhibitor
Target Aurora kinase B

Mechanism of action

Serine/threonine-protein kinase Aurora-B inhibitor

Primary target: Aurora kinase B

Approval history

Authority Status Date
NMPA clinical trials

Frequently asked questions

What is chiauranib?

chiauranib is a serine/threonine-protein kinase aurora-b inhibitor.